Disease Overview：Myopia（MYO）
Myopia, or nearsightedness, is a common refractive error characterized by axial elongation of the eyeball or excessive corneal/lens curvature, resulting in light focusing anterior to the retina. This leads to blurred distance vision while preserving clear near vision. Prevalence is especially high among East Asian populations, with progressive myopia—particularly childhood-onset—posing risks for pathological complications including posterior staphyloma, choroidal neovascularization, and retinal detachment. Diagnosis relies on comprehensive ophthalmic evaluation: manifest and cycloplegic refraction, axial length measurement via optical biometry (e.g., IOLMaster), corneal topography, and fundus examination. Management options range from corrective spectacles and contact lenses to pharmacologic interventions (e.g., low-dose atropine) and surgical correction—including SMILE (Small Incision Lenticule Extraction), LASIK, and ICL (Implantable Collamer Lens) implantation—for eligible adults with stable refraction.
China offers distinct advantages for myopia treatment: world-class ophthalmology centers—many affiliated with top-tier universities—employ FDA- and CE-approved excimer and femtosecond lasers, with surgeons trained in advanced techniques like SMILE, which boasts faster recovery and reduced dry eye incidence. Clinical outcomes align with international benchmarks: over 95% of SMILE patients achieve uncorrected visual acuity of 20/20 or better at one year postoperatively. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising safety or efficacy. As a dedicated medical tourism agency, we facilitate seamless access for international patients—vetting JCI-accredited hospitals, coordinating pre-arrival diagnostics, securing transparent all-inclusive pricing, and providing end-to-end support from visa assistance to postoperative follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Myopia
Non-Surgical / Conservative Management
Target Criteria: Children <12 years (progression control), adults with ≤−6.00 D refractive error, contraindications to surgery, or preference for non-invasive care.
- •Comprehensive Refractive Exam + Axial Length Measurement: $45–$65
- •Orthokeratology (OK) Lens Fitting & 6-Month Follow-up Package:
- Custom OK lenses (1 pair, 1-year lifespan): $780 - Quarterly monitoring (4 visits/year): $240
- •Low-Dose Atropine (0.01%) Therapy (1-year supply + monitoring):
- Biannual cycloplegic refraction & IOP check: $130
- •Behavioral Intervention Program (digital screen time management, outdoor activity coaching): $180 (one-time, includes 3 sessions + app access)
Surgical / Procedural Interventions
Eligibility Criteria: Age ≥18 years, stable refraction (≤0.50 D change in past 2 years), corneal thickness ≥480 µm, no active keratoconus or severe dry eye.
- •Preoperative Workup (mandatory for all procedures): $210
- •SMILE (Small Incision Lenticule Extraction):
- SMILE with enhanced centration algorithm (for astigmatism >2.00 D): $3,350
- •FS-LASIK (Femtosecond Laser-Assisted In Situ Keratomileusis):
- Wavefront-Guided FS-LASIK: $3,050
- •ICL (Implantable Collamer Lens) – Posterior Chamber Implant:
- Non-toric ICL: $5,200
Special/Complex Condition Management
- •Progressive Myopia in Children (<12 years) with ≥1.00 D/year progression:
- •High Myopia (≥−8.00 D) with posterior staphyloma or lattice degeneration:
- •Myopia-Related Glaucoma Suspect (elevated IOP + optic nerve asymmetry):
Quick Selection Guide
- •Children aged 6–12, rapid progression (>0.75 D/year): Start with 0.01% atropine + OK lenses ($1,280/year) — highest evidence for slowing axial elongation.
- •Adults 18–40, −3.00 to −6.00 D, stable refraction, budget <$3,000: FS-LASIK ($2,200–$2,750) offers fastest visual recovery and lowest complication risk.
- •Adults ≥40, −6.00 to −10.00 D, thin cornea or dry eye: SMILE ($2,450–$3,100) preserves corneal biomechanics better than LASIK.
- •Patients ≥−10.00 D or corneal thickness <480 µm: ICL implantation ($5,200–$6,400) is the only viable surgical option.
- •Elderly patients (>60 years) with cataract co-morbidity: Cataract extraction with toric/EDOF IOL ($3,800–$4,600) corrects myopia *and* lens opacity simultaneously.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Myopia Medical Vacation Packages
Curated transparent all-inclusive packages combining Myopia treatment with China top medical destinations:
